8/29/24 16:27 | 8/28/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | SVP Fina | S | -6,846 | 1,205.3 | 0 | -6 | -23 | 19 | I | | | | | | | | | | | | | | |
2/12/24 16:02 | 2/9/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | SVP Fina | S | -4,689 | 953.31 | 0 | -5 | -17 | 24 | D | | | | | | | | | | | | | | |
1/25/24 16:17 | 1/23/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | SVP Cont | M.d | 4,777 | 477.67 | 0 | 10 | 52 | 29 | D | | | | | | | | | | | | | | |
1/4/24 16:22 | 1/3/24 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | SVP Cont | M.d | 4,777 | 477.67 | 0 | 10 | 59 | 27 | D | | | | | | | | | | | | | | |
12/29/23 16:04 | 12/27/23 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | SVP Cont | S | -2,097 | 856.71 | 0 | -2 | -9 | 24 | D | | | | | | | | | | | | | | |
12/26/23 16:08 | 12/21/23 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | SVP Cont | S.m | -1,630 | 844.30 | 0 | -2 | -7 | 27 | D | | | | | | | | | | | | | | |
8/25/23 16:03 | 8/23/23 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | SVP Cont | M.d | 2,798 | 399.66 | 0 | 7 | 29 | 31 | D | | | | | | | | | | | | | | |
3/27/23 16:37 | 3/23/23 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | SVP Cont | S | -1,768 | 806.47 | 0 | -2 | -7 | 29 | D | | | | | | | | | | | | | | |
2/7/23 16:10 | 2/3/23 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | SVP Cont | M.d | 1,352 | 270.43 | 0 | 5 | 19 | 31 | D | | | | | | | | | | | | | | |
10/7/22 16:03 | 10/5/22 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | SVP Cont | S | -1,381 | 749.00 | 0 | -2 | -6 | 28 | D | | | | | | | | | | | | | | |
10/5/22 16:10 | 10/3/22 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | SVP Cont | S | -2,423 | 724.00 | 0 | -3 | -10 | 30 | D | | | | | | | | | | | | | | |
4/11/22 16:40 | 4/8/22 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | SVP Cont | M.d | 2,714 | 364.23 | 0 | 7 | 29 | 33 | D | | | | | | | | | | | | | | |
4/1/22 16:07 | 3/31/22 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | SVP Cont | M.d | 3,816 | 317.97 | 0 | 12 | 62 | 31 | D | | | | | | | | | | | | | | |
8/24/21 16:04 | 8/20/21 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | SVP Cont | M.d | 2,418 | 179.13 | 0 | 14 | 63 | 35 | D | | | | | | | | | | | | | | |
8/24/21 16:04 | 8/23/21 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | SVP Cont | S.d | -3,133 | 655.31 | 0 | -5 | -12 | 35 | D | | | | | | | | | | | | | | |
7/22/20 16:31 | 7/20/20 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | M.d | 1,907 | 156.01 | 0 | 12 | 107 | 24 | D | | | | | | | | | | | | | | |
7/22/20 16:31 | 7/21/20 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | S.d | -2,381 | 642.04 | 0 | -4 | -14 | 24 | D | | | | | | | | | | | | | | |
6/17/20 16:02 | 6/15/20 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | M.d | 443 | 47.07 | 0 | 9 | 78 | 21 | D | | | | | | | | | | | | | | |
6/17/20 16:02 | 6/16/20 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | S.d | -2,101 | 590.89 | 0 | -4 | -14 | 21 | D | | | | | | | | | | | | | | |
4/3/20 16:05 | 4/1/20 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | M.d | 37 | 30.63 | 0 | 1 | 7 | 19 | D | | | | | | | | | | | | | | |
4/3/20 16:05 | 4/1/20 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | S.d | -586 | 488.41 | 0 | -1 | -6 | 19 | D | | | | | | | | | | | | | | |
1/27/20 16:04 | 1/24/20 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | M.d | 15 | 30.63 | 0 | 1 | 3 | 19 | D | | | | | | | | | | | | | | |
12/23/19 16:02 | 12/20/19 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | M.d | 12 | 30.63 | 0 | 0 | 2 | 19 | D | | | | | | | | | | | | | | |
12/13/19 18:03 | 12/12/19 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | M.d | 161 | 52.03 | 0 | 3 | 20 | 18 | D | | | | | | | | | | | | | | |
12/13/19 18:03 | 12/13/19 | REGN | Regeneron Pharmaceuticals, Inc. | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | S.d | -633 | 376.14 | 0 | -2 | -8 | 18 | D | | | | | | | | | | | | | | |
4/18/19 19:04 | 4/18/19 | REGN | Regeneron Pharmaceuticals Inc | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | M.d | 7 | 21.25 | 0 | 0 | 2 | 15 | M | | | | | | | | | | | | | | |
1/18/19 17:01 | 1/18/19 | REGN | Regeneron Pharmaceuticals Inc | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | M.d | 3 | 21.25 | 0 | 0 | 1 | 14 | M | | | | | | | | | | | | | | |
12/20/18 17:36 | 12/19/18 | REGN | Regeneron Pharmaceuticals Inc | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | M.dm | 194 | 46.99 | 0 | 4 | 41 | 14 | D | | | | | | | | | | | | | | |
12/20/18 17:36 | 12/20/18 | REGN | Regeneron Pharmaceuticals Inc | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | S.d | -663 | 358.97 | 0 | -2 | -12 | 14 | D | | | | | | | | | | | | | | |
8/31/18 16:02 | 8/30/18 | REGN | Regeneron Pharmaceuticals Inc | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | M.d | 1 | 21.25 | 0 | 0 | 1 | 9 | D | | | | | | | | | | | | | | |
1/17/18 16:07 | 1/16/18 | REGN | Regeneron Pharmaceuticals Inc | NY | Health | Drug | Pharmaceutical Preparations | Fenimore Christopher R. | NY | O | VP Contr | M.d | 3 | 21.25 | 0 | 0 | 2 | 8 | D | | | | | | | | | | | | | | |